Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:00 PM
Ignite Modification Date:
2025-12-24 @ 10:00 PM
NCT ID:
NCT06139432
Eligibility Criteria:
Inclusion Criteria:
* Men or women over 18 years old
* Under the care of the GHU PARIS Psychiatry and Neurosciences or EPS Ville Evrard.
* Suffering from an episode of catatonia according to the DSM-5 CRITERIA
* Persistence of catatonia criteria according to DSM-5 after 24 hours of lorazepam treatment or contraindication to lorazepam or poor tolerance to lorazepam
* Patient (or guardian) having given informed and written consent
* Beneficiary of a social security plan
Exclusion Criteria:
* Malignant catatonia
* Pregnant or breastfeeding women
* Patients with contraindications to tCDS, namely patients with a defibrillator or a pacemaker, brain stimulator, presence of intracranial metals, uncovered craniectomy or after trepanning.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06139432
Study Brief:
Protocol Section:
NCT06139432